APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress

Biosci Rep. 2018 Aug 29;38(4):BSR20171713. doi: 10.1042/BSR20171713. Print 2018 Aug 31.

Abstract

Two coding sequence variants (G1 and G2) of Apolipoprotein L1 (APOL1) gene have been implicated as a higher risk factor for chronic kidney diseases (CKD) in African Americans when compared with European Americans. Previous studies have suggested that the APOL1 G1 and G2 variant proteins are more toxic to kidney cells than the wild-type APOL1 G0, but the underlying mechanisms are poorly understood. To determine whether endoplasmic reticulum (ER) stress contributes to podocyte toxicity, we generated human podocytes (HPs) that stably overexpressed APOL1 G0, G1, or G2 (Vec/HPs, G0/HPs, G1/HPs, and G2/HPs). Propidium iodide staining showed that HP overexpressing the APOL1 G1 or G2 variant exhibited a higher rate of necrosis when compared with those overexpressing the wild-type G0 counterpart. Consistently, the expression levels of nephrin and podocin proteins were significantly decreased in the G1- or G2-overexpressing cells despite the maintenance of their mRNA expressions levels. In contrast, the expression of the 78-kDa glucose-regulated protein ((GRP78), also known as the binding Ig protein, BiP) and the phosphorylation of the eukaryotic translation initiation factor 1 (eIF1) were significantly elevated in the G1/HPs and G2/HPs, suggesting a possible occurrence of ER stress in these cells. Furthermore, ER stress inhibitors not only restored nephrin protein expression, but also provided protection against necrosis in G1/HPs and G2/HPs, suggesting that APOL1 risk variants cause podocyte injury partly through enhancing ER stress.

Keywords: APOL1; ER stress; Podocyte.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Amino Acid Sequence
  • Apolipoprotein L1 / chemistry
  • Apolipoprotein L1 / genetics*
  • Base Sequence
  • Cell Line
  • Endoplasmic Reticulum Chaperone BiP
  • Endoplasmic Reticulum Stress*
  • Genetic Variation
  • Humans
  • Podocytes / metabolism
  • Podocytes / pathology*
  • Renal Insufficiency, Chronic / genetics*
  • Renal Insufficiency, Chronic / pathology

Substances

  • APOL1 protein, human
  • Apolipoprotein L1
  • Endoplasmic Reticulum Chaperone BiP
  • HSPA5 protein, human